Skip to content

Efficacy of Titanium Granules in the Treatment of Periodontal Intrabony Defects

Comparative Efficacy of Titanium Granules Over Hydroxyapatite in the Treatment of Periodontal Intrabony Defects: A Clinico-radiographic Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04932161
Enrollment
12
Registered
2021-06-21
Start date
2021-08-31
Completion date
2022-12-31
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrabony Periodontal Defect

Keywords

Intrabony defects, Titanium Granules

Brief summary

The ideal goal of the periodontal treatment is not only to prevent the progression of the disease, but also the regeneration and reconstruction of lost tissues. Many surgical techniques have been used to regenerate intrabony defects (IBD). Titanium stimulates activation of the complement system, surface binding of platelets, and platelet activation as reflected by increased levels of platelet-derived growth factor, which is a substantial promoter of bone growth. Hence we may speculate that using a bone substitute made of titanium may be positive from the perspective of bone formation in osseous defects.

Detailed description

Titanium granules consist of irregular porous granules of commercially pure titanium. The porous properties may lead to ingrowth of newly formed bone.The osseointegrating response to titanium may be the result of the potent activation of the intrinsic coagulation system and the subsequent release of growth factors from platelets.Therefore, the aim of this study is to compare the effect of titanium particles and hydroxyapatite on osseous regeneration in intrabony defects. After reflection of flap and degranulation, bone graft i.e., titanium particles (test group) or hydroxyapatite(control group) will be placed in the void created by the defect and sutures will be placed.

Interventions

PROCEDURETitanium Granules

After degranulation of the intrabony defect, titanium particles will be placed in the defect and will be sutured.

After degranulation of the intrabony defect, hydroxyapatite will be placed in the defect and will be sutured.

Sponsors

SVS Institute of Dental Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Systemically healthy male and female patients of age \>18 years with two-walled or three-walled intrabony defects and probing pocket depths (PPD) of \>3mm.

Exclusion criteria

Medically compromised patients, patients \<18 years of age, pregnant women, heavy smokers, and patients who underwent radiotherapy or chemotherapy are excluded.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Attachment Levelfrom baseline to 6 monthsAssessment of clinical attachment level using UNC-15 probe at baseline and post operatively at 3 and 6 months.
Probing Depthfrom baseline to 6 monthsAssessment of probing depth using University of North Carolina(UNC)-15 probe at baseline and postoperatively at 3 and 6 months.
Bone Regenerationat 3 months and 6 monthsRadiovisiography (RVG) will be used to assess bone regeneration achieved post operatively after 3 months and 6 months.

Secondary

MeasureTime frameDescription
Plaque Indexfrom baseline to 6 monthsAssessment of plaque (PI) - according to Turesky modification of Quigley and Hein Plaque Index, 1970.
Gingivitisfrom baseline to 6 monthsAssessment of Gingivitis (GI) - according to Loe H and Silness P, 1963.

Countries

India

Contacts

Primary ContactR V Chandra, MDS;DNB;PhD
viswachandra@hotmail.com9908183071

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026